Regarding the publication "Rivaroxaban versus warfarin in patients with non-valvular atrial fibrillation and stage IV-V chronic kidney disease".

Shoar, Saeed; Shoar, Nasrin; Naderan, Mohammad; Modukuru, Venkat R

Shoar, Saeed; Shoar, Nasrin; Naderan, Mohammad; Modukuru, Venkat R.

Afiliação

Shoar S; Department of Clinical Research, ScientificWriting Corporation, Houston, TX. Electronic address: saeedshoar@scientificwriting.org.
Shoar N; Faculty of Medicine, Kashan University of Medical Sciences, Kashan, Iran.
Naderan M; Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Modukuru VR; Department of Surgery, Metropolitan Hospital Center, New York Medical College, Manhattan, NY.

Am Heart J ; 223: 110, 2020 05.

Article em En | MEDLINE | ID: mdl-32386597

Assuntos

Fibrilação Atrial; Insuficiência Renal Crônica; Anticoagulantes; Dabigatrana; Humanos; Rivaroxabana; Varfarina

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fibrilação Atrial / Insuficiência Renal Crônica Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google